» Articles » PMID: 37077498

Receded Near Point of Convergence As a Predictor of Mild Cognitive Impairment in the General Geriatric Population: Results from a Population-based Study

Overview
Specialty Ophthalmology
Date 2023 Apr 20
PMID 37077498
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To investigate the relationship between near point of convergence (NPC) and mild cognitive impairment (MCI) in the general elderly population.

Methods: The present report is a part of the Tehran Geriatric Eye Study (TGES): a population-based cross-sectional study conducted on individuals 60 years of age and above living in Tehran, Iran using the multi-stage stratified random cluster sampling method. Cognitive status was assessed using the Persian version of the Mini-Mental State Examination (MMSE). All study participants underwent complete ocular examination including measurement of uncorrected and best-corrected visual acuity, objective and subjective refraction, cover testing, NPC measurement, and slit-lamp biomicroscopy.

Results: The data of 1190 individuals were analyzed for this report. The mean age of the participants analyzed was 66.82±5.42 (60-92y) and 728 (61.2%) of them were female. Patients with MCI had a significantly more receded NPC compared to subjects with normal cognitive status (10.89±3.58 7.76±2.71 cm, <0.001). In the multivariable logistic regression model and in the presence of confounding variables, a receded NPC was statistically significantly associated with an increased risk of MCI (odds ratio: 1.334, 95% confidence interval: 1.263 to 1.410, <0.001). According to receiver operating characteristic (ROC) analysis, a cut point NPC> 8.5 cm (area under the curve: 0.764, <0.001) could predict the presence of MCI with a sensitivity and specificity of 70.9% and 69.5%, respectively.

Conclusion: A receded NPC can be clinically proposed as a predictor of MCI in older adults. It is recommended that elderly with a receded NPC>8.50 cm undergo detailed cognitive screening for a definite diagnosis of MCI. In this case, the necessary interventions can be carried out to slow down MCI progression to dementia.

References
1.
Guo Y, Xu W, Liu F, Li J, Cao X, Tan L . Modifiable risk factors for cognitive impairment in Parkinson's disease: A systematic review and meta-analysis of prospective cohort studies. Mov Disord. 2019; 34(6):876-883. DOI: 10.1002/mds.27665. View

2.
Xu H, Garcia-Ptacek S, Jonsson L, Wimo A, Nordstrom P, Eriksdotter M . Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality. Neurology. 2021; 96(17):e2220-e2230. PMC: 8166426. DOI: 10.1212/WNL.0000000000011832. View

3.
Holden S, Van Dok E, Pelak V . Co-occurrence of Convergence Insufficiency and Cognitive Impairment in Parkinsonian Disorders: A Pilot Study. Front Neurol. 2019; 10:864. PMC: 6696607. DOI: 10.3389/fneur.2019.00864. View

4.
Sabbagh M, Boada M, Borson S, Chilukuri M, Doraiswamy P, Dubois B . Rationale for Early Diagnosis of Mild Cognitive Impairment (MCI) Supported by Emerging Digital Technologies. J Prev Alzheimers Dis. 2020; 7(3):158-164. DOI: 10.14283/jpad.2020.19. View

5.
Quinet J, Schultz K, May P, Gamlin P . Neural control of rapid binocular eye movements: Saccade-vergence burst neurons. Proc Natl Acad Sci U S A. 2020; 117(46):29123-29132. PMC: 7682339. DOI: 10.1073/pnas.2015318117. View